View Archive: 2008 |
2007 |
2006 |
2005 |
2004 |
2003 |
2002 |
2001 |
2000 |
1999 |
1998November 10, 2008
Cytokinetics Files Replacement Shelf Registration Statement
November 10, 2008
Cytokinetics Announces Data from a Clinical Trial of CK-1827452 in Stable Heart Failure Patients Presented at the 2008 Scientific Sessions of the American Heart Association
November 5, 2008
Cytokinetics to Present at November Healthcare Conferences
November 3, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 2008 Scientific Sessions of the American Heart Association
October 30, 2008
Cytokinetics, Incorporated Reports Third Quarter 2008 Financial Results
October 23, 2008
Cytokinetics to Announce Third Quarter Results on October 30, 2008
October 23, 2008
Cytokinetics Announces Data Relating to GSK-923295 and SB-743921 Presented at the 2008 EORTC-NCI-AACR International Symposium
October 20, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at the 12th Annual Scientific Meeting of the Japanese Heart Failure Society
October 15, 2008
Cytokinetics Announces Data Relating to GSK-923295 and SB-743921 to be Presented at the 2008 EORTC-NCI-AACR International Symposium
October 10, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 12th Annual Scientific Meeting of the Japanese Heart Failure Society
September 30, 2008
Cytokinetics to Present at JMP Securities Healthcare Focus Conference
September 24, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 Presented at the 2008 Annual Heart Failure Society of America Conference
September 17, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the 2008 Annual Heart Failure Society of America Conference
September 16, 2008
Cytokinetics Announces Strategic Realignment of Workforce and Operations
September 8, 2008
Cytokinetics Announces Interim Clinical Trial Data Relating to Ispinesib Presented at the 2008 ASCO Breast Cancer Symposium
September 5, 2008
Cytokinetics Announces the Initiation of Third Phase IIa Clinical Trial of CK-1827452
September 2, 2008
Cytokinetics Announces Interim Clinical Trial Data Relating to CK-1827452 Presented at the European Society of Cardiology Congress 2008
August 29, 2008
Cytokinetics Announces Clinical Trials Data Relating to Ispinesib to be Presented at the 2008 ASCO Breast Cancer Symposium
August 28, 2008
Cytokinetics to Present at the Newsmakers in the Biotechnology Industry Conference
August 27, 2008
Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452
August 25, 2008
Cytokinetics Announces Clinical Trials Data Relating to CK-1827452 to be Presented at the European Society of Cardiology Congress 2008
July 31, 2008
Cytokinetics, Incorporated Reports Second Quarter 2008 Financial Results
July 24, 2008
Cytokinetics to Announce Second Quarter Results on July 31, 2008
June 30, 2008
Cytokinetics Announces Clinical Data Regarding Ispinesib in Combination with Capecitabine
June 19, 2008
Cytokinetics Announces Third Extension of Research Term Under Collaboration with GlaxoSmithKline
June 16, 2008
Cytokinetics Announces Late Breaking Trials Presentation Relating to CK-1827452 at the 2008 Heart Failure Congress of the European Society of Cardiology
June 13, 2008
Cytokinetics Provides Updates from Phase I Clinical Trials of CK-1827452
June 9, 2008
Cytokinetics to Present Clinical Data on CK-1827452, a Selective Cardiac Myosin Activator, at the 2008 Heart Failure Congress of the European Society of Cardiology
June 5, 2008
Cytokinetics Announces Clinical Trial Data Related to SB-743921 Presented at the 10th International Conference on Malignant Lymphoma
June 4, 2008
Cytokinetics to Present at Needham Healthcare Conference
June 3, 2008
Cytokinetics Announces Clinical Trials Data Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology
May 29, 2008
Cytokinetics Announces Clinical Trials Data Related to SB-743921 to be Presented at the 10th International Conference on Malignant Lymphoma
May 16, 2008
Cytokinetics Announces Addition to Board of Directors
May 16, 2008
Cytokinetics Announces Clinical Trials Data to be Presented at the 2008 Annual Meeting of the American Society of Clinical Oncology
May 15, 2008
Cytokinetics to Hold Annual Meeting of Stockholders
May 12, 2008
Cytokinetics to Present at May Healthcare Conferences
April 29, 2008
Cytokinetics, Incorporated Reports First Quarter 2008 Financial Results
April 29, 2008
Cytokinetics Announces the Initiation of Second Phase IIa Clinical Trial of CK-1827452
April 22, 2008
Cytokinetics to Announce First Quarter Results on April 29, 2008
April 17, 2008
Cytokinetics Announces Selection of Development Compound that Activates the Skeletal Sarcomere
April 16, 2008
Cytokinetics Announces Data Relating to GSK-923295 Presented at the 2008 American Association of Cancer Research Annual Meeting
April 7, 2008
Cytokinetics Announces Non-clinical and Clinical Data Relating to GSK-923295 To be Presented at the 2008 American Association of Cancer Research Annual Meeting
March 31, 2008
Cytokinetics Announces Presentation of Non-clinical Data Relating to CK-1827452 at the 2008 Annual Scientific Sessions of The American College of Cardiology
March 25, 2008
Cytokinetics to Present Non-clinical Data on Cardiac Myosin Activator CK-1827452 at the 2008 Annual Scientific Sessions of The American College of Cardiology
March 24, 2008
Cytokinetics Announces Positive Results from an Interim Analysis of an Ongoing Phase IIA Clinical trial of CK-1827452 in Patients with Stable Heart Failure
February 5, 2008
Cytokinetics to Present at BIO CEO and Investor Conference
January 31, 2008
Cytokinetics, Incorporated Reports Fourth Quarter and Year End 2007 Financial Results
January 24, 2008
Cytokinetics to Announce Fourth Quarter and Year End Results on January 31, 2008
